Chester County News and Community Website
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced a 1-for-50 reverse split of its Class A common stock, set to take effect at 5:00 pm Eastern time …
Helius Medical Announces 1-for-50 Reverse Stock Split Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a 1-for-50 reverse stock split of its common stock. The company’s board approved the move following authorization granted by stockholders during …
Windtree Therapeutics Announces Reverse Stock Split to Maintain Nasdaq Compliance Read More
YARDLEY, PA — Optinose, Inc. (NASDAQ: OPTN) has announced a 1-for-15 reverse stock split, set to take effect on December 30, 2024, at 5:00 p.m. Eastern Time. Starting December 31, …
Optinose Announces 1-for-15 Reverse Stock Split Read More
NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently concluded its 2024 Special Meeting of Stockholders with significant decisions impacting the company’s capital structure. Shareholders approved all proposals outlined in the …
Traws Pharma Announces Key Approvals and Reverse Stock Split at 2024 Special Meeting Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) has announced a reverse stock split of its common stock at a ratio of 1-for-25. The split will take effect at 12:01 a.m. …
Trevena Announces Reverse Stock Split to Regain Nasdaq Compliance Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) is set to undergo a significant transformation with a reverse stock split at a ratio of 1-for-10, effective June 6, 2024, …
STRATA Skin Sciences Announces Reverse Stock Split to Meet Nasdaq’s Minimum Bid Price Requirement Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NASDAQ: WINT), a biotechnology firm, has declared a significant adjustment to its stock structure through a 1-for-18 reverse stock split. This strategic move, set …
Windtree Therapeutics Announces Reverse Stock Split in Strategy to Boost Market Compliance Read More
BERWYN, PA — In a recent Special Meeting of Shareholders, Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) revealed that its stockholders had given the green light for a reverse stock split. The …
Virpax Pharmaceuticals Shareholders Approve Reverse Stock Split Amid Nasdaq Compliance Efforts Read More